99 related articles for article (PubMed ID: 10223233)
1. Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells.
Lin HL; Liu TY; Lui WY; Chi CW
Cancer; 1999 May; 85(9):1937-42. PubMed ID: 10223233
[TBL] [Abstract][Full Text] [Related]
2. Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel.
Lin HL; Liu TY; Wu CW; Chi CW
Br J Cancer; 1999 Oct; 81(3):416-22. PubMed ID: 10507765
[TBL] [Abstract][Full Text] [Related]
3. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the multidrug resistance P-glycoprotein in acetaminophen-induced toxicity in hepatoma-derived HepG2 and Hep3B cells.
Manov I; Bashenko Y; Hirsh M; Iancu TC
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):213-24. PubMed ID: 16930294
[TBL] [Abstract][Full Text] [Related]
5. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells.
Kang DI; Kang HK; Gwak HS; Han HK; Lim SJ
Drug Deliv; 2009 Jul; 16(5):261-7. PubMed ID: 19538007
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death.
Uen YH; Ko PH; Yin PH; Liu TY; Chi CW; Lui WY
Int J Oncol; 2008 Dec; 33(6):1263-70. PubMed ID: 19020760
[TBL] [Abstract][Full Text] [Related]
7. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.
Liu J; Qi S; Zhu H; Zhang J; Li Z; Wang T
Chin Med J (Engl); 2002 May; 115(5):759-62. PubMed ID: 12133551
[TBL] [Abstract][Full Text] [Related]
8. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
Fong WF; Wan CK; Zhu GY; Chattopadhyay A; Dey S; Zhao Z; Shen XL
Planta Med; 2007 Mar; 73(3):212-20. PubMed ID: 17318783
[TBL] [Abstract][Full Text] [Related]
9. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of activator protein 1 activity by berberine in human hepatoma cells.
Fukuda K; Hibiya Y; Mutoh M; Koshiji M; Akao S; Fujiwara H
Planta Med; 1999 May; 65(4):381-3. PubMed ID: 10364850
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma.
Jia L; Xu H; Zhao Y; Jiang L; Yu J; Zhang J
Cancer Invest; 2008 Dec; 26(10):977-83. PubMed ID: 19093255
[TBL] [Abstract][Full Text] [Related]
12. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
14. Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells.
Bjørnland K; Lehne G; Johansen HT; Fodstad O; Rugstad HE; Aasen AO; Ree AH
Oncol Res; 1998; 10(5):255-62. PubMed ID: 9802060
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma up-regulates expression and activity of P-glycoprotein in human peripheral blood monocyte-derived macrophages.
Puddu P; Fais S; Luciani F; Gherardi G; Dupuis ML; Romagnoli G; Ramoni C; Cianfriglia M; Gessani S
Lab Invest; 1999 Oct; 79(10):1299-309. PubMed ID: 10532592
[TBL] [Abstract][Full Text] [Related]
16. Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway.
Zhang H; Ozaki I; Mizuta T; Matsuhashi S; Yoshimura T; Hisatomi A; Tadano J; Sakai T; Yamamoto K
Cancer; 2002 Aug; 95(4):896-906. PubMed ID: 12209735
[TBL] [Abstract][Full Text] [Related]
17. Effects of diode 808 nm GaAlAs low-power laser irradiation on inhibition of the proliferation of human hepatoma cells in vitro and their possible mechanism.
Liu YH; Cheng CC; Ho CC; Pei RJ; Lee KY; Yeh KT; Chan Y; Lai YS
Res Commun Mol Pathol Pharmacol; 2004; 115-116():185-201. PubMed ID: 17564317
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
[TBL] [Abstract][Full Text] [Related]
19. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression.
Zheng LH; Bao YL; Wu Y; Yu CL; Meng X; Li YX
Cancer Lett; 2008 Dec; 272(1):102-9. PubMed ID: 18703276
[TBL] [Abstract][Full Text] [Related]
20. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle.
Tang H; Tang XY; Liu M; Li X
Clin Chim Acta; 2008 Aug; 394(1-2):81-8. PubMed ID: 18485897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
